In the hypoxic TME, the HIF-1α-mediated transcriptional upregulation of LOX not only increases the expression of ITG-α5 and its ligand fibronectin in tumor cells, but also induces collagen crosslinking and fibronectin assembly, forming the mechanical barrier to prevent drug transport [136,137]. Here, LOX is linked to neoplasm.